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Subacute autonomic and sensory
ganglionopathy: a postmortem case
Acute autonomic and sensory neuropathy
(AASN) is characterised by severe autonomic
dysfunction, sensory deficit, and relatively
well or fully preserved motor nerve
function.1–4 The disease sometimes has a
chronic course.2 4 Detailed information is
limited because there have been so few
reports of the postmortem examination of
AASN.2–4 This case provides histopathologi-
cal evidence for autonomic and sensory gan-
glionopathy in AASN.
A 30 year old Japanese man had abdominal
pain and a rise in body temperature to 40°C
on 1 January 1990. On 23 January, he felt
prickling and paraesthesia in all his limbs. On
14 February he could no longer walk due to
severe prickling of the entire body. On 2
March, he became bedridden because of
orthostatic hypotension. He experienced
mild weakness in the all limbs, dysarthria,
and dysphagia. On 13 March, he was
transferred to our hospital. Physical examin-
ation on admission showed anhidrosis, uri-
nary retention, hyposalivation, and paralytic
ileus. There was no history of intoxication by
drugs or food preceding the illness. His blood
pressure was 122/70 mm Hg when supine
and 80/46 mm Hg when sitting with no
increase in heart rate. His skin was dry. Neu-
rologically, the right pupil was round and 5.5
mm in diameter, whereas the left was oval
shaped and 6.0 mm in diameter. The light
reflex was sluggish, and the convergence
reflex absent bilaterally. Muscle power was
mildly weak in his limbs, and there was mod-
erate limb ataxia. Deep tendon reflexes were
decreased. Sensation was lost to all modalities
over his entire body, including the face.
Complete blood cell and serum biochemistry
findings were normal. Epstein-Barr virus
antibody titres were not raised in the serum.
His CSF was normal. Motor conduction
velocities (MCVs) and compound motor
action potentials were normal in the right
median nerve and the right tibial nerve. No
sensory nerve action potentials (SNAPs)
were evoked in the bilateral sural nerves. The
coeYcient of variation of the R-R interval on
his ECG was reduced (1.9%). In October,
dysarthria, dysphagia, and muscle weakness
gradually lessened. Despite the improvement
in muscle power, severe sensory impairment
and paraesthesia of the entire body, as well as
orthostatic hypotension persisted. His re-
sponse to plasmapheresis and high dose cor-
ticosteroids was very poor. Two years later, at
the age of 33, he died of heart failure.
No tumour was found on general patho-
logical postmortem examination. The dorsal
fasciculus at all levels of the spinal cord
showed an almost complete loss of myeli-
nated fibres, and the number of dorsal horn
cells were decreased. Both the gracilis and
cuneatus neurons of the medulla oblongata
were slightly decreased. The dorsal roots
were atrophic. No detectable changes could
be seen in the lateral and ventral fasciculus;
nor any clear reduction in the number of
neurons in the ventral or lateral horn at Th4
levels. In the cervical (figure A), thoracic, and
lumbar dorsal root ganglia, only a few
neurons could be seen under low power, with
Nageotte nodule formation. In the cervical
(figure B) and lumbar sympathetic ganglia,
the number of neurons were severely reduced
without lymphocyte infiltration. Examination
of the dorsal root showed severe loss of
myelinated fibres, whereas the ventral root of
L3 appeared normal.
This case seemed to be compatible with
AASN. Parasympathetic failure was reflected
in the loss of salivation, decreased intestinal
peristalsis, and bladder atony. Absence of
sweating, orthostatic hypotension, and slow-
ness of pupillary dilatation indicated sympa-
thetic failure. Sensory neuropathy was con-
firmed by an electrophysiological study. The
absence of SNAPs in the normal MCVs is
best explained by selective involvement of
the neurons in lumbar dorsal root ganglia.
Neuropathologically, there were no changes
in the lumbar ventral roots, but there was
severe loss of myelinated fibre in the dorsal
roots. Severe degeneration was found in the
lumbar dorsal root ganglia neurons at all lev-
els. The slight decrease in the gracilis and
cuneatus neurons in the medulla oblongata
is thought to be due to anterograde trans-
synaptic degeneration, as is the slight de-
crease in the number of dorsal horn cells. As
judged by the pathological findings, the site
of the sensory nervous system lesion in this
case was the lumbar dorsal root ganglia.
Similar severe degeneration was found in the
sympathetic ganglion neurons, but neurons
in the lateral horn remained intact. The site
of the autonomic nervous system lesion in
our case, therefore, is considered in the sym-
pathetic ganglion. Our case showed the same
degree of neuropathologically severe auto-
nomic and sensory ganglinopathy. There
have been a few postmortem records of
AASN.2–4 Fagius et al2 showed that the main
lesions were in the dorsal root ganglia, dorsal
roots, and posterior columns, but they did
not examine the autonomic neurons. They
speculated that the main lesion responsible
for autonomic symptoms was in peripheral
nerves. Tohgi et al4 reported severe patho-
logical changes in preganglionic and post-
ganglionic neurons of the autonomic nerv-
ous system, posterior columns, and the
peripheral nerves, but there they did not
describe any pathological findings for the
lumbar dorsal root ganglia. Thus they
suggested that the main lesion of sensory
symptoms was in the peripheral nerves judg-
ing from sural nerve biopsy. One report
showing both autonomic and sensory gan-
glion involvement was by Stoll et al,3 who
described a 68 year old man with AASN. He
died of sudden cardiac arrest four months
after onset. In contrast with our case, their
patient showed rapid onset (two days) and a
very good response to corticosteroids. A
postmortem examination detected numer-
ous lymphocytic infiltrates and degeneration
in the autonomic and sensory ganglia and, to
a lesser extent, in the dorsal roots, dorsal
columns, and brainstem. Thus their case is
similar to ours in neuropathological lesions.
Despite the diVerences in response to
therapy, inflammatory change, and disease
course between their patient and ours the
pathological findings indicate that the dis-
ease, selectively involving both autonomic
and sensory systems, is ganglionopathy, not
neuropathy.
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Intracranial calcification with IgG ë
M-proteinaemia: a case report
Recently Kosaka reviewed 16 cases of slowly
progressive presenile cortical dementia
thought to be a clinicopathological entity with
pathological features characterised by circum-
scribed lobar atrophy, diVuse neurofibrillary
tangles, and calcification of the Fahr type and
named diVuse neurofibrillary tangles with
(A) Section from the lumbar dorsal root ganglia: There are only a few normal lumbar dorsal root
ganglia neurons. (B) Section from the sympathetic ganglion: normal nerve cell bodies have disappeared
and been replaced by clusters of cells (“nodules of Nageotte” (arrows)). Originally×100.
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calcification.1 However, the pathogenesis and
biochemical findings of this new entity are not
known in detail. Herein, we report on a
patient with presenile dementia, intracranial
calcification, andM-proteinaemia, which may
play some part in the development of
intracranial calcification with dementia.
A 66 year old man was admitted with
dementia, which had been apparent since
about 60 years of age. At the age of 62 he
started to lose spontaneity and at the age of
66 gait disturbance occurred. In addition he
showed slurred dysarthria, mild muscle
rigidity, bilateral pyramidal signs, and mild
truncal ataxia. Dementia slowly progressed
and his dementia scales were as follows.
Hasegawa’s dementia rating scale revised
was 16/30 points, mini mental state examin-
ation was 20/30 points, the Japanese
Wechsler adult intelligence scale revised
showed verbal IQ 83, performance IQ 67,
and total IQ 74. His routine laboratory
investigations were normal. In particular,
serum calcium and phosphorus were within
the normal range. Twenty four hour urinary
calcium and phosphorus were also within the
normal range. Serum pyruvate, lactate, vita-
mins, including 1.25-(OH)2-vitamin D, and
analysis of amino acids were within normal
limits. Wasserman’s test, rheumatoid arthri-
tis test, antinuclear antibodies, and DNA
antibodies were all non-reactive. Endocrino-
logical tests showed a slightly low concentra-
tion of parathyroid hormone (173 pg/ml;
normal range 180–560 pg/ml), other tests,
including the Ellsworth Howard test and
thyroid function, gave normal results. Immu-
noelectrophoresis showed the presence of
IgG ë M-protein in serum. Bence-Jones pro-
tein was not detected in urine. Routine CSF
tests were normal for cell counts and protein
concentrations. The concentrations of amy-
loid â (Aâ) 1–40 and Aâ1–42 in CSF meas-
ured by enzyme linked immunosorbent assay
(ELISA)2 were 1659 fmol/ml and 179.1
fmol/ml respectively, which were within the
normal ranges. The concentration of tau
protein in CSF measured by a sandwich
ELISA (Innogenetics, Belgium) was raised
at 457 pg/ml. Bone marrow was normal.
Chest radiography and CT showed calcifica-
tion of the aorta, pleura, pericardium, and
diaphragm. Brain CT and MRI (figure) dis-
closed calcification in the basal ganglia, the
floor of the cortices, subcortical white
matter, and cerebellum. Magnetic resonance
angiography showed no evidence of arterio-
sclerosis. The cerebral blood flow measured
by 123I-IMP SPECT showed hypoperfusion
in the frontotemporal lobes (figure). Neuro-
physiological tests including auditory brain-
stem responses, sensory evoked potentials,
and peripheral nerve conduction velocities
were normal.
DiVuse neurofibrillary tangles with calcifi-
cation is a presenile dementia as proposed by
Kosaka1 and its clinical characteristics are (a)
presenile onset, (b) slowly progressive cortical
dementia, (c) more common temporofrontal
focal signs rather than parietooccipital signs,
(d) atrophy of the frontotemporal lobes on
CT or MRI, (e) calcification of the bilateral
globus pallidus and dentate nucleus, (f)
hypoperfusion in the frontotemporal lobes on
SPECT or PET, (g) normal serum calcium
and phosphorus concentrations .
Our present case showed presenile slowly
progressive cortical dementia and loss of
spontaneity. Brain CT and MRI disclosed
symmetric non-arteriosclerotic, intracranial
severe calcification. Although parathyroid
hormone was slightly low, other hormones
measured and serum calcium and phospho-
rus were within normal limits, suggesting that
intracranial calcification was idiopathic. The
CSF study of Aâ and tau protein is
considered a biological diagnostic marker for
Alzheimer’s disease.3–5 Decreased Aâ1–42
and increased tau protein are specific for
diagnosis of Alzheimer’s disease. The CSF
concentration of Aâ1–42 was within the nor-
mal range and the CSF concentration of tau
protein was high which may indicate the
absence of deficits in Aâ metabolism but the
presence of neurofibrillary tangles. Besides,
our patient had IgG ë M-proteinaemia with-
out Bence-Jones protein. The study of bone
marrow indicated no malignancy. The gam-
mopathy was considered to be monoclonal
gammopathy with undetermined signifi-
cance. Previously Nishiyama et al6 reported a
41 year old woman with idiopathic intracra-
nial calcification associated with
M-proteinaemia, followed by multiple my-
eloma.Her symptoms were dystonia, gait and
speech disturbance, and dementia. This case
suggested an association between M protein-
aemia and dementia with intracranial calcifi-
cation. Tentolouris et al7 reported three cases
of familial calcification of the aorta and
calcific aortic valve disease associated with a
monoclonal ë-chain gammopathy. They indi-
cated that immunological abnormalities were
associated with calcifications, but they did
not assess the CNS.
Without the pathological evidence, clini-
cally this case appeared to be consistent with
the criteria for diVuse neurofibrillary tangles
with calcification and CSF studies may indi-
cated the presence of neurofibrillary tangles.
At present, little is known about the biologi-
cal and pathogenetic findings in diVuse neu-
rofibrillary tangles with calcification. The
present case suggests that M-proteinaemia
may play a part in the development of
dementia with intracranial calcification such
as diVuse neurofibrillary tangles with calcifi-
cation. Further biochemical studies are nec-
essary in patients with dementia and intracra-
nial calcifications.
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Subacute combined degeneration of the
spinal cord after nitrous oxide
anaesthesia: role of magnetic resonance
imaging
Among all the possible causes of myelopathy,
subacute combined degeneration of the
spinal cord, neurological complication of
vitamin B12 (cobalamin) deficiency, is one of
the less often seen.
We report a case of subacute combined
degeneration of the spinal cord occurring
postoperatively after nitrous oxide anaesthe-
sia in a patient previously undiagnosed to be
vitamin B12 deficient.
A 73 year old woman underwent surgery
for knee prothesis; forty days later she
suVered a femoral fracture due to an
accidental fall. Two weeks after surgical
stabilisation performed under general anaes-
thesia with nitrous oxide, the patient com-
plained of gradual onset of loss of gait and
weakness of the upper limbs associated with
hypoaesthesia of her hands and feet.
Neurological deficits progressively worsened
so that the patient was admitted to the hospi-
tal with severe tetraparesis with bowel and
bladder dysfunction. Neurological examin-
ation disclosed paraplegia with pronounced
loss of strength of the arms, generalised
hyporeflexia, and loss of vibration sense; cra-
nial nerves were normal, mental signs were
not evident. Magnetic resonance imaging
(1.0 T) of the cervicothoracic spine disclosed
considerable cord swelling; no abnormalities
of signal intensity in T1 weighted sagittal
images were evident, whereas abnormally
increased signal intensity lesions were de-
tected in T2 weighted images in the posterior
cord (figure, A) involving, to a lesser degree,
also the lateral columns (figure, C). Brain
MRI was unremarkable. Laboratory studies
showed macrocytic (mean corpuscolar vol-
ume 110 fl, normal 82 to 96 fl; packed cell
volume 38%) anaemia (12 g/dl), low concen-
trations of iron (16 µg/dl, normal 37–145
µg/dl), and vitamin B12 (53 pg/ml, nor-
mal>200 pg/ml); folate was within normal
values.
Gastric endoscopy disclosed the presence
of chronic atrophic gastritis. Iliac crest
biopsy showed a hypercellular bone marrow
with an appreciable number of megaloblastic
forms.
Diagnosis of subacute combined degenera-
tion of the spinal cord was established. Treat-
ment with cobalamin was immediately
started (1 mg intramuscularly daily for seven
days and thereafter once monthly), with con-
tinuous and progressive improvement; vita-
min B12 values became normal in two weeks
and remained stable. At eight month follow
up the patient was able to stand up and walk
unassisted; strength was normal in the upper
limbs whereas hypoaesthesia with impair-
ment of vibratory sense, even if improved,
persisted altered in four limbs. Magnetic
resonance imaging showed considerable im-
provement of previous abnormalities, only
faint hyperintensities in the posterior col-
umns of the cervical spinal cord persisting;
cord swelling was no longer detected (figure,
B, D).
Pernicious anaemia is the most common
cause of vitamin B12 deficiency. The spinal
cord is usually aVected first by vitamin B12
deficiency and often exclusively.
Neurological dysfunctions are due to
progressive demyelination, sometimes fol-
lowed by axonal loss, which starts in the pos-
terior columns and spreads anteriorly involv-
ing the lateral and anterior columns; the
process begins in the lower cervical and
upper thoracic cord, spreading up and down
the cord as well. The same neuropathological
pattern can be found also in peripheral and
optic nerves and, more rarely, in the white
matter of the brain.1 2
The progression of pathological changes in
the spinal cord is reflected in the course of the
disease; this results in a clinical picture
consisting of the association of myelopathy
and polyneuropathy.
Mental signs are frequent, ranging from
irritability, apathy, somnolence, suspicious-
ness, and emotional instability to a pro-
nounced confusional or depressive psychosis
with intellectual deterioration. Replacement
therapy with cobalamin is usually followed by
almost complete resolution of symptoms.
Demyelination is disclosed at MRI as high
signal intensity lesions on T2 weighted
images, explained by increased water
content.2 A slight degree of expansion was
seldom noted.3 Pronounced, multifocal con-
trast enhancement of the cervical and tho-
racic sections of the spinal cord after admin-
istration of gadolinium DTPA, indicating
blood-CNS barrier disruption, was recently
reported.3 Even if involvement of posterior
columns is the origin of a characteristic MRI
pattern, it is important to notice that similar
findings can be found also in cases of purely
spinal forms of multiple sclerosis, combined
system disease of non-pernicious anaemia
type, peripheral neuropathy (as in POEMS
syndrome), and other rare pathological con-
ditions.
Our patient, not known as vitamin B12
deficient, developed subacute combined
GE T2 weighted images of the cervical spine in the midsagittal (380/18/18:TR/TE/FA) and axial
(510/15/15:TR/TE/FA) planes at the level of C2 at admission (A, C) and 8 months later after
replacement therapy with cobalamin (B,D). At admission cord swelling is evident;high intensity
lesions involve the posterior (C, arrows), and to a lesser degree, also the lateral (C, arrowheads)
columns of the entire cervical spinal cord. Control examination shows the persistence of only faint
hyperintensities in the posterior columns (D, arrow); the volume of the spinal cord is normal.
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degeneration of the spinal cord two weeks
after nitrous oxide anaesthesia given during
surgery for stabilisation of a femoral fracture.
At the present time there is growing
acceptance that the clinical picture of
neurological dysfunction due to contact with
nitrous oxide takes the form of vitamin B12
deficiency. This finding is supported by a
sizeable body of laboratory investigations
indicating that nitrous oxide exerts its bio-
logical eVects exclusively through interfer-
ence with vitamin B12, necessary for DNA
synthesis and for the maintenance of myelin
sheaths.4
The neurological eVects of long term
nitrous oxide exposure were first reported in
1978 in several people who used nitrous
oxide for recreational purpose.4 5 A
neurological syndrome identical to that of
vitamin B12 deficiency was noted.6
Whereas short term nitrous oxide exposure
in healthy people seems to have no appreci-
able sequelae, the administration of nitrous
oxide anaesthesia in patients with unsus-
pected vitamin B12 deficiency can induce
neurological changes, highlighting a previous
subclinical condition.
Preoperative vitamin B12 concentrations
should be obtained in patients with increased
mean corpuscular volume indexes, or af-
fected with gastric mucosa atrophy or previ-
ous gastric or intestinal resections. In this way
vitamin B12 deficiency would be easily
corrected before and after anaesthesia and
surgery to avoid possible neurological com-
plications.
ALBERTO BELTRAMELLO
GIOVANNI PUPPINI
ROBERTO CERINI
GHASSAN EL-DALATI
Institute of Radiology
MICHELA MANFREDI
Institute ofNeurological Sciences, University of Verona,
Italy
GIORGIO RONCOLATO
DOMENICO IDONE
LAURA DE TOGNI
Division of Neurology, Pederzoli Clinic, Peschiera,
Verona
MICHELANGELO TURAZZINI
Division of Neurology, Legnago General Hospital,
Verona, Italy
Correspondence to: Dr Alberto Beltramello, Insti-
tute of Radiology, Policlinico Borgo Roma, Strada
Le Grazie, 37100 Verona, Italy. Telephone 0039 45
8074779; Fax 0039 45 582445; email:
abeltram@sun1.univr.it
1 Duprez TP, Gille M, Vande Berg BC, et al. MRI
of the spine in cobalamin deficiency: the value
of examining both spinal and bone marrow.
Neuroradiology 1996;38:511–5.
2 Timms SR, Cure JK, Kurent JE. Subacute com-
bined degeneration of the spinal cord: MR
findings. AJNR Am J Neuroradiol 1993;14:
1224–7.
3 Küker W, Hesselmann V, Thron A, et al. MRI
demonstration of reversible impairment of the
blood-CNS barrier function in subacute com-
bined degeneration of the spinal cord. J Neurol
Neurosurg Psychiatry 1997;62:298–9.
4 Stacy CB,Di Rocco A,Gould RJ.Methionine in
the treatment of nitrous-oxide-induced neu-
ropathy and myeloneuropathy. J Neurol 1992;
239:401–3.
5 Filippo TS, Holder WD. Neurologic degenera-
tion associated with nitrous oxide anesthesia in
patients with vitamin B12 deficiency.Arch Surg
1993;128:1391–5.
6 Amess JAL, Burman JF, Rees GM, et al. Mega-
loblastic haemopoiesis in patients receiving
nitrous oxide. Lancet 1978;12:339–42.
Acute polyneuropathy with chronic
lymphocytic leukaemia and parapro-
teinaemia: response to chlorambucil
and prednisolone
Paraproteinaemic polyneuropathies are usu-
ally chronic and respond poorly to
treatment.1 An exception to this is seen in the
POEMS syndrome (polyneuropathy, orga-
nomegaly, endocrinopathy, monoclonal gam-
mopathy, and skin changes),2 in which
polyneuropathy may improve after treatment
for the osteosclerotic myeloma with which it
is often associated. Progressive paraprotein-
aemic neuropathies may also be associated
with multiple myeloma, Waldenstrom’s mac-
roglobulinaemia, monoclonal gammopathy
of undetermined significance, amyloidosis,
and Castleman’s disease.3 Monoclonal gam-
mopathy is often detected in patients with
chronic lymphocytic leukaemia,4 but the
association between paraproteinaemic
polyneuropathy and chronic lymphocytic
leukaemia has not previously been reported.
A 73 year old woman with diet controlled
diabetes developed, over three days, progres-
sive, bilateral leg weakness without sensory
disturbance or sphincter symptoms. Examin-
ation disclosed a profound flaccid leg weak-
ness with areflexia and flexor plantar re-
sponses. There was a partial right third cranial
nerve palsy and poor adduction of the left eye,
which improved spontaneously within two
weeks of admission. The spleen tip was palpa-
ble, but there was no hepatomegaly or
lymphadenopathy. Investigations included a
white blood cell count of 160 × 109/l, platelets
90 × 109/l with normal haemoglobin, electro-
lytes, and liver function.An IgG ê-paraprotein
band (33 g/l) was detected on protein electro-
phoresis.Morphology and immunophenotyp-
ing of the white cells in peripheral blood and
bone marrow were diagnostic of chronic lym-
phocytic leukaemia. MRI of the brain and
thoracolumbar spine was normal. Total pro-
tein in CSF was 1.3 g/l (normal 0.3–0.6 g/l)
and glucose was 3.4 mmol/l (plasma 4.7
mmol/l). No atypical lymphocytes were seen
on a centrifuged specimen. Nerve conduction
studies performed 10 days after admission
showed absent sural nerve sensory action
potential and distal slowing of motor conduc-
tion in both upper and lower limbs (ulnar
nerve distal motor latency 4.7 ms and
conduction velocity 46m/s; common peroneal
nerve distal motor latency 8.5 ms and
conduction velocity 34 m/s). Ulnar nerve F
response was 33.6 ms and no F responses
were detected from common peroneal nerve
stimulation. No antibodies against myelin
associated glycoprotein were detected in the
serum. A diagnosis of postinfectious acute
inflammatory demyelinating polyradiculopa-
thy (AIDP) prompted treatment with intra-
venous immunoglobulin. After six weeks
without improvement treatment with 60 mg
prednisolone daily was started. A sural nerve
biopsy showed severe loss of large and small
myelinated fibres, but no malignant infiltra-
tion or deposition of amyloid light chains or
cryoglobulin. After 10 weeks without clinical
improvement and still wheelchair bound,
treatment with 10 mg chlorambucil daily was
started. Within a week of this treatment she
could lift her legs oV the bed. After six cycles
of combined treatment (two weeks 10 mg
chlorambucil, 40 mg prednisolone daily,
followed by two weeks oV treatment) she was
able to walk with a stick. Her white cell count
had fallen to 8 × 109/l (46% lymphocytes) and
her paraprotein to 8 g/l.
Chronic lymphocytic leukaemia is the most
common human leukaemia but infrequently
causes neurological symptoms. The predomi-
nant neurological complications of chronic
lymphocytic leukaemia are due to meningeal5
or peripheral nerve infiltration,6 both of
which were excluded in our patient. Although
rare cases of axonal peripheral neuropathy
have been described in patients with chronic
lymphocytic leukaemia,6 we think that this is
the first case of a paraproteinaemic demyeli-
nating polyneuropathy associated with
chronic lymphocytic leukaemia. This case is
not typical of the POEMS syndrome in that
the neuropathy was of relatively acute onset,
there was no endocrinopathy or skin changes
and, in POEMS, the underlying haematologi-
cal disorder is usually osteosclerotic my-
eloma. An autoimmune aetiology of the
polyneuropathy seems likely as quantitative
defects of the immunoglobulins in chronic
lymphocytic leukaemia can disrupt the anti-
idiotype network’s regulation, resulting in
autoimmune manifestations that may aVect
peripheral nerves. In addition, peripheral
demyelination may be caused by binding of
the paraprotein and complement C3b to
myelin associated glycoproteins.7 It is of
interest that specific treatment of the lympho-
proliferative condition in our patient resulted
in a reduction in the paraprotein and a
dramatic clinical improvement.
This case emphasises the diversity of
haematological malignancies that can mani-
fest as paraproteinaemic demyelinating
polyneuropathy. The prognosis for neuropa-
thies associated with paraproteinaemia is
generally poor, but this case suggests that
chronic lymphocytic leukaemia, in addition
to POEMS, is an example in which treatment
of the underlying disorder may modify the
natural history of the neuropathy.
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CORRESPONDENCE
Endovascular electroencephalography
during an intracarotid amobarbital test
with simultaneous recordings from 16
electrodes
Recently, Boniface and Antoun1 reported
endovascular EEG during intra-arterial amo-
barbital tests using an endovascular guide
wire as the diVerent electrode for bipolar
recordings against an extracranial surface
electrode (T3) or an average reference. They
concluded that their technique was feasible to
identify intracranial epileptiform discharges
and was less invasive than other intracranial
EEG methods with the advantage that it was
possible to move the guide wire between dif-
ferent intracranial sides. They also mentioned
“the potential to achieve more in a bipolar
format when the electrical characteristics of
the electrode are optimised”.
Our experience with this technique2
prompted us to use a multilead catheter devel-
oped for cardiological examinations (Pathfind-
erTM, Cardima, 47201 Lakeview Boulevard,
Fremont, CA 94538, USA) with eight pairs of
electrodes (electrode length 0.5 mm, interelec-
trode spacing 2 mm; electrode pair spacing 6
mm).This allows bipolar recording simultane-
ously from each electrode to an extracranial
surface electrode (FZ) (figure). Our endovas-
cular EEG shows pulse artefacts in some leads,
which are a common problem of this
technique,1–3 but they were less pronounced
than other recordings.1 Using the tip of the
guide wire as the diVerent electrode, as done
by previous groups,1–3 has the disadvantage
that recordings are achieved from a single area
at one time only and that the guide wire has to
be moved to record from other parts of the
temporal lobe. The catheter we used, however,
provides simultaneous recordings from 16 dif-
ferent points over a length of 72 mm of the
temporal lobe. Such a technique may be of
interest during pharmacological activation of
epileptogenic foci with short acting
barbiturates,4 and especially during the int-
racarotid amobarbital test, as this test is
routinely performed during presurgical evalu-
ation of patients with medically intractable
temporal lobe epilepsy and is known to
activate the epileptic focus in more than half of
the patients.5 The clinical use of this technique
awaits further evaluation in an appropriate
number of patients.
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Standardising care and clinical trials
In his editorial on the Brain Trauma Founda-
tion guidelines for the management of severe
head injury, Kirkpatrick argues that stand-
ardisation of care is a prerequisite for the
conduct of multicentre randomised trials.1 A
similar concern seems to have motivated the
European Brain Injury Consortium to de-
velop its “expert opinion” based guidelines.2
This is not the case. Providing that a trial is
large enough, randomisation will ensure that
the intervention and control groups are iden-
tical with regard to known and unknown
confounders. It is conceivable that the size of
the intervention eVect may vary a little
depending on the other aspects of care given,
but not the direction of the eVect. Patients in
the future will almost certainly receive diVer-
ent forms of care than they do today, and
treatments shown to be eVective today may
be more or less eVective in the future, but the
direction of the eVect will be the same. Rather
than standardise care, it would be more use-
ful to make sure that clinical trials were large
enough to detect reliably moderate but clini-
cally important treatment eVects. Even
though thousands of patients each year are
treated with hyperventilation, barbiturates,
mannitol, and steroids, clinical trials of these
interventions, even in aggregate, have in-
volved less than a few thousand patients, and
for hyperventilation, mannitol, and barbitu-
rates, existing trials comprise less than a few
hundred patients. It is not surprising that the
Brain Trauma Foundation was unable to
define evidence based standards of care.
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Endovascular EEG using a catheter with 16 electrodes. Bipolar recording between every single electrode
and an extracranial surface electrode at FZ. (The electrodes were placed one after another over a length
of 72 mm,Cat1 refers to the distal electrode at the tip of the catheter and Cat16 to the proximal
electrode at the end of the line of electrodes.)
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Kirkpatrick and Pickard reply:
We are grateful for the letter from Roberts
which highlights the concept that randomised
controlled trials can detect small treatment
benefits provided such trials are large
enough. Although correct in theory, this con-
cept still assumes that the pathology treated
shows some degree of homogeneity. It is now
becoming clear that the number of known
and unknown confounding variables with
acute brain injury dramatically increases the
number of patients required to prove efficacy.
At some point this number exceeds that
which is practicable and aVordable, especially
as the regulatory authorities demand that
pharmaceutical phase III trials collect vast
and expensive data sets. The randomised
controlled trials which have shown treatment
eYcacy (for example, streptokinase for acute
mycocardial infarction, aspirin and dipyrida-
mole for the prevention of stroke and
myocardial infarction, nimodipine for sub-
arachnoid haemorrhage, and carotid endar-
terectomy for stroke prevention) have consid-
ered conditions with well defined end points
sharing common pathological mechanisms.
Head injury does not fall into this stereotype
in view of the multiple interacting and
opposing pathological mechanisms and the
range of possible outcomes which are difficult
to quantify.
Confounding variables influence outcome
in particular conditions to diVerent degrees.
Attention to blood pressure, fluid balance,
and systemic oxygenation may have only a
modest influence on outcome after myocar-
dial infarction, but are known to have a pro-
found influence on the victim of brain injury.
A specific treatment may have variable effects
on diVerent pathophysiological events oper-
ating within the same condition. Thus hyper-
ventilating a patient with head injury with
associated cerebral oligaemia is likely to be
harmful, whereas this approach for raised
intracranial pressure due to hyperaemia is
more appropriate. By contrast the use of
mannitol (which increases cerebral blood
flow), may be beneficial for the first, but
potentially harmful for the second. Hence the
eVect of a given intervention is not a simple
matter of magnitude as suggested by Roberts,
as the direction of the eVect may diVer in dif-
ferent subgroups.
Retrospective analysis of subgroups in
phase III randomised control trials to correct
for such imbalances have been received
rightly with scepticism, but such an exercise
can be used to direct the design of future tri-
als to reduce the “noise” in the system. The
suggestion that head injury subgroups be
identified and a more stable physiological
background be provided, is not dissimilar to
that adopted for the randomised control tri-
als of carotid endarterectomy, in which sub-
populations were defined according to the
grade of stenosis and the presenting symp-
tom stereotype. If this had not been done, the
eYcacy would have been diluted to extinc-
tion.
The purpose of publishing standards of
care in the head injury environment is largely
educational, highlighting the lack of defini-
tive evidence and the diYculty in obtaining
it. None the less, ironing out key important
variables will help to generate a substrate for
testing intervention on defined subpopula-
tions which share common pathology. Even
if the standard proves to be harmful, delivery
to the test population will provide a more
stable pathophysiological baseline and a
greater chance of showing individual thera-
peutic eYcacy.
P J KIRKPATRICK
J D PICKARD
BOOK REVIEWS
Head Injury. Physiology and
Management of Severe Closed Injury.
Edited by PETER REILLY AND ROSS BULLOCK.
(Pp 478; £135.00.) Published by Chapman
and Hall Medical, London. 1997. ISBN
0-412-58540-5.
For neurosurgeons, head injuries are always
with us. They exist like the drones of a
bagpipe tune, unchanging in the background
while the music goes on elsewhere. This is
perhaps why the last major textbook to be
published on the subject was that of Jennett
and Teasdale in 1981. However, for that
small, and diminishing, band of neurosurgi-
cal researchers, head injuries provide ideal
“case material” for the investigation of new
ideas on the ways that insults aVect the nerv-
ous system and how outcomes might be
improved. The fruits of that thinking and
investigation are admirably covered in this
new book. It represents a tripartite coopera-
tion between those centres in the United
Kingdom, Australia, and the United States
which have a particular interest in the
mechanisms of head injury and management
of the patient. Although not all of the content
is new, the chapters on the eVects of injury at
the cellular level represent a particularly use-
ful summary of what has become a very com-
plex pathophysiological process. Similarly the
chapters on new methods of investigation in
those with head injury, such as PET, SPECT,
MR spectroscopy, and transcranial Doppler,
represent, for the average neurosurgeon, a
useful summary of the applications of new
and rapidly developing technologies.
Although promising developments in the
field of neuroprotection and perhaps eventu-
ally brain repair can be perceived on the dis-
tant horizon, of its nature, neuroprotection
can at best prevent or minimise secondary
damage. To achieve major miracles we will no
doubt have to await the more distant promise
of brain repair. If such treatments do eventu-
ally become available there is no doubt that
any such techniques will prove diYcult and
very expensive. The non-specialist may turn
therefore to the regrettably small section on
prevention. In the United Kingdom the
number of head injuries shows a small but
welcome continuing decline, although not all
countries are so fortunate. Head injury rates
vary widely even in the so called “developed”
world. On a recent visit to Amsterdam I was
astounded to see, in such a cycle oriented
city, not one single rider wearing a protective
cycle helmet. Perhaps the time has come to
make these compulsory. There is clearly
much still to do in the way of head injury
protection. Although seatbelts, airbags, and
antilock brakes represent good solid progress,
considering the remarkable survivals which
occur in the high speed crashes in Formula
One Grand Prix motor racing, there is clearly
a lot more which could be achieved given the
potential will and the financial investment.
The book is a welcome addition to the
neurosurgical literature. It is well produced
and beautifully presented. Although rather
expensive it will no doubt become an
indispensable companion for those of us who
still have to care for these distressing and still
too frequent cases.
DAVID G HARDY
Gait Disorders of Aging. Falls and
Therapeutic Strategies. Edited by JOSEPH
C MASDEU, LEWIS SUDARSKY, and LESLIE
WOLFSON. (Pp 350; £61.00.) Published by
Lippincot -Raven, Philadelphia. 1997. ISBN
0-316-54915-0.
Community studies show that around 30% of
people aged 65 and over fall each year. Only
10% to 15% of falls result in serious injury
but 92% of hip fractures and 96% of wrist
fractures in older women are caused by
falling. There are important consequences
even when no serious physical injury occurs.
The anxiety caused by falling can result in
loss of confidence and self imposed restric-
tions on activities, eventually resulting in
admission to institutional care.
This book is based on an annual course
held at the American Academy of Neurology
on gait disorders in elderly people, and the
contributors represent some of the partici-
pants, including neurologists, geriatricians,
physiotherapists, and physiologists. Its stated
aim is to be of use to those in clinical practice
but also to those planning research.
The book is well structured. It commences
with overviews on the physiology of static
balance and gait, the eVects of aging on them,
and clinical research methodology. These are
mostly excellent, apart from an overdetailed
exposition of the neurophysiology of gait in
cats, the relevance of which to two legged
humans is diYcult to grasp. All the authors
are keen to stress the importance of detailed
assessment, which is undoubtedly true but
becomes rather repetitive.
There follow chapters on a suggested
nosology of gait disorders and a clinical
approach to diagnosis, both models of clarity
and practicality. The detailed discussions of
the common underlying diagnoses such as
parkinsonism and cerebrovascular disease are
generally useful with the exception of that on
vestibular and cerebellar disorders. It is
abundantly clear which authors deal regularly
with older people and which do not, as the
latter briefly mention elderly people as a
“special group” leaving the reader to wonder
whether the rest of the chapter has any
relevance to them at all. The final six chapters
discuss evaluation and intervention, includ-
ing risk factor intervention, physical therapy
and balance, and resistance training. The
chapter on physical therapy is superb, con-
centrating on a sample case to illustrate how
appropriate treatment is planned.
This book usefully brings together a wide
and multidisciplinary literature on a complex
and fascinating problem. The mistaken as-
sumption that old age itself is a cause of poor
balance and falls is still widely held and as a
result many professionals display a depress-
ingly defeatist attitude to their management.
This book confirms that impaired gait and
balance in an older person constitutes a syn-
drome with a rich diVerential diagnosis, and
that even when a treatable cause cannot be
found,much can be done to reduce disability.
NICKI COLLEDGE
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Epilepsy and pregnancy. Edited by T
TOMSON, L GRAM, M SILLANPAA, AND S I
JOHANNESSEN. (Pp 215; £38.00.) Published
by Wrightson biomediacal publishing,
Petersfield. 1997. ISBN 1 871816 36 X.
The use of antiepileptic drugs in women of
childbearing age is one of the most thorny
issues regularly facing neurologists. The
stakes are high but there is no universally
agreed approach to management. This book
explores various aspects of the problem,
including teratogenicity, epilepsy control in
pregnancy, and the consequence of seizures
to mother and child in pregnancy and at
delivery. There are valuable chapters describ-
ing increasing knowledge of the mechanisms
of teratogenicity of antiepileptic drugs and
the minor developmental and cognitive con-
sequences of anticonvulsant exposure in
utero; an area of increasing concern. Breast
feeding is also covered. I suspect that most
readers would expect to discover a detailed
review of current evidence in relation to tera-
togenicity. This section is really the nub of the
book but it lacks suYciently detailed statistics
for a text devoted to this subject and I think
that it is just a gateway to the source
literature. There are also several key issues in
relation to new drugs: how and when they
should be used in women of child bearing
age; how to manage their pregnancies; and
how to coordinate postmarketing surveil-
lance. These matters are not considered; nor
is there any information on the most recent
antiepileptic drugs, even though some data
are available from postmarketing surveillance
and from animal studies. This book covers a
broad range of issues competently in a series
of brief chapters with good literature citations
but lacks a suYciently detailed analysis of
teratogenicity of antiepileptic drugs to be of
real help to the clinician in making decisions
in this potential minefield.
MARK MANFORD
Neurosurgical Aspects of Pregnancy.
Neurological Topics Series. Edited by C
LOFTUS. (Pp 255.) Published by the
American Association of Neurological
Surgeons, Park Ridge, ILL. 1996. ISBN
1-879284-36-7.
Pregnancy is a condition encountered infre-
quently in neurosurgical practice and yet it
complicates many facets of patient manage-
ment, including investigation, drug therapy,
anaesthesia, and surgery. As such, clinicians
may be unfamiliar with the most appropriate
way to manage the condition, nor able to
counsel the patient fully as to the precise risk
both to the foetus and herself. Although this
information is available in the literature it is
not readily accessible, particularly in an
emergency setting. This book is designed to
fill that void by distilling the necessary infor-
mation into a single slim volume.
This text has been produced by the Ameri-
can Association of Neurological Surgeons as
part of its Neurosurgical Topics series. It
follows the familiar pattern of a review of the
literature which is concluded by a short series
of multiple choice questions intended as revi-
sion for trainees. The book is divided into
three parts. The first is a general section
which is equally applicable to various disci-
plines, not just to neurosurgery. It includes
the potential foetal toxicity of commonly used
drugs, the risks associated with diagnostic
imaging and with anaesthesia, haemostatic
and thrombotic considerations, and the
physiological changes to cardiovascular and
cerebrovascular function that occur during
pregnancy.The second section covers specific
neurosurgical disorders such as back pain,
carpal tunnel syndrome, pituitary tumours,
subarachnoid haemorrhage, venous throm-
bosis, benign intracranial hypertension, hy-
drocephalus, and ventriculoperitoneal shunt
management. The final part discusses patient
positioning and foetal monitoring for surgery,
the intrauterine diagnosis of developmental
disorders, the current status of intrauterine
surgery, and ethical issues surrounding the
management of brainstem death and the per-
manent vegetative state.
This is a truly excellent volume. All that
could be reasonably expected to be covered in
a book on this subject is here. The chapters
are clear, concise, and have been referenced
extensively for further reading. Every practis-
ing neurosurgeon should have ready access to
this work.
ROBERT MACFARLANE
Handbook of Stroke. Edited by DAVID O
WEIBERS, VALERY L FEIGEN, and ROBERT D
BROWN. (Pp 450; £34.50.) Published by
Lippincot-Raven, Philadelphia. 1997. ISBN
0-316-94760-1.
I approach handbooks with a mixture of
eagerness and dread. Some are what they
purport to be, fit into the palm and are easy to
use in the clinical setting, Others, however,
require no little eVort to lift and are clearly
detailed tomes. This text fits snugly into the
white coat pocket of the junior doctor and is
comprehensive in its summary of the assess-
ment and treatment of patients presenting
with stroke—the authors clearly dislike the
overused term “cerebrovascular accident”
which they point out contributes nothing to
the idea that this is a complex disorder
requiring comprehensive appraisal and
therapy.
The early chapters provide an extensive
guide to the assessment and treatment of the
“neurological patient”. Smaller sections fol-
low on less obvious subjects such as the
telephone assessment of subjects and more
detailed diVerential diagnosis.
Opinions as to the appropriate treatment of
cerebral infarction presenting early are evolv-
ing rapidly and this text takes an active line,
suggesting thrombolytic therapy in line with
the certain recent trials and the licensing of
tPA for treatment of stroke in the United
States.
Rehabilitation becomes the priority in the
long term management of the stroke patient
and this section is short in comparison with
others. By contrast, the appendices provide
detailed illustrations, disability scales, risk
scales, and algorithms, although colour dia-
grams could have lifted the illustrations
somewhat and some of the assessment forms
did not copy well.
Overall, this is an extremely useful tool for
the admitting doctor in the assessment and
care of the patient with suspected cerebrovas-
cular disease. It should be noted, however,
that treatment options suggested are slanted
towards practice in the United States making
this portion of the book less helpful in the
United Kingdom, where practice tends to be
more conservative.
Despite this, the publication clearly and
concisely fulfills its role as a handbook and
should stimulate the physician into further
examination of this important subject.
ALASTAIR LANSBURY
Neurologic Disorders in Women. Edited
by MERIT E CUDKOWICZ AND MICHAEL C
IRIZARRY. (Pp 162.) Published by
Butterworth-Heinemann, Oxford. 1997.
ISBN 0-–7506–9745–8.
I was a little bemused when first presented
with this book,Neurologic Disorders in Women.
Like many things in life, I suppose I had
always accepted that it was more hazardous
to be male. After all, are we not always telling
men with vascular disease that whereas they
can reduce some of their risk factors they
can’t change being male, or being aware of
possible x linked adrenoleukodystrophies in
young men with what has been labelled
aggressive multiple sclerosis and then there
are the x linked muscular dystrophies. So
where is the neurological problem in being
female? Migraines and epilepsy fluctuate with
the menstrual cycle, pregnancy alters the
course of multiple sclerosis and the connec-
tive tissue diseases, and then there are the
potential complications of hormone treat-
ment be it in the shape of the oral contracep-
tive pill or hormone replacement therapy.
And maybe we do have more headaches. But
is that really enough on which to base a book?
So with these preconceptions I opened the
book with curiosity.
Cudkowicz and Irizarry (one woman, one
man: an important balance in having such a
book accepted) and colleagues from the
Massachusetts General Hospital, have di-
vided neurology into nine broad categories
including, epilepsy, stroke, headache, and
multiple sclerosis. In each chapter a brief
overview is provided with particular reference
to the incidence and prevalence in females
and noting any sex specific features of the
disease. Emphasis is then placed on the inter-
action of the disease with the female func-
tions of menarche, menstruation, meno-
pause, and reproduction including both the
hormonal and other aspects of pregnancy,
oral contraception and hormone replace-
ment. Much of what is discussed is small
print that would be omitted from larger
textbooks—for example, that whereas issues
surrounding a young woman with multiple
sclerosis or a connective tissue related vascu-
litis who wishes to get pregnant are generally
known, what if she had Parkinson’s disease or
chronic inflammatory demyelinating
polyneuropathy or if that same woman
wished to breast feed? Such issues are
considered. Important pharmacological areas
are discussed in detail; the interaction of
antiepileptic drugs with other medications, in
particular the oral contraceptive pill, the tera-
togenicity of certain medications, and the role
of the oral contraceptive pill and hormone
replacement therapy in cerebrovascular dis-
ease. The neurological complications, both
direct and paraneoplastic, of predominantly
female malignancies are also described; a
female presenting with a Lambert-Eaton
myasthenic syndrome might well have a small
cell carcinoma of the lung but could also have
a similar carcinoma of the uterus or breast
carcinoma and then there is the rare stiV
“man” syndrome described in women with
breast carcinoma.
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So, despite my starting position that there
was not such a specific gap in the neurological
literature, I have been converted. Perhaps the
book should have been named The Hazards of
being a Female with a Neurological Disease as
the strengths of this book lie in describing the
role that the menstrual cycle, reproductive
functions,and associated factors have in
altering the course of a disease or how they
alter the therapeutic options. The other great
strength of this book is its thorough and up to
date referencing. Small and concise, this book
will provide an excellent reference source for
all physicians treating neurological disorders
in women.
GILLIAN HALL
Behavioural Neurology and the Legacy
of Norman Geschwind. Edited by STEVEN
C SCHACHTER and ORRIN DEVINSKY. (Pp 304;
£84.50.) Published by Lippincott-Raven,
Philadelphia. 1997. ISBN 0-397-51631-2.
As the title suggests, this edited book is a trib-
ute to the late Norman Geschwind written by
30 or so of his former colleagues and pupils.
The first quarter is extremely engrossing and
consists of series of short essays dealing with
Geschwind as “educator”, “advisor”, “role
model”, “teacher”, “mentor”, etc. The most
enduring impression left by this section is what
a truly remarkable person he was. I finished
many chapters wishing that my exposure had
not been limited to hearing a single lecture.
Subsequent sections of the book are more
conventional and cover Geschwind’s contri-
butions in the areas of language disorders,
apraxia, disconnection syndromes, frontal
lobe disorders, epilepsy, and aspects of
cerebral dominance.Most of the chapters are
very well written, although there could
perhaps have been a greater editorial input to
avoid repetition. For those who have trained
more it is salutary to be reminded of the
monumental contributions made by this
founding father in such a wide range of
topics. The book is fitting tribute to a great
man. It should be bought by anyone with an
interest in the origins and development of
behavioural neurology and neuropsychology
but the high price is likely to deter a wider
readership.
JOHN HODGES
Readers might be interested in the
following:
Neuromuscular Diseases During
Development. Edited by F CORNELIO, G
LANZI, and E FEDRIZZI. (Pp 164; £36.00).
Published by John Libbey and Co Ltd,
London, 1997. ISBN 0-86196-541-8.
Handbook of Vestibular Rehabilitation.
Edited by LINDA M LUXON and ROSALYN A
DAVIES. (Pp l60; £24.50). Published by
Whurr Publishers Ltd, London 1997. ISBN
1-870332-17-2.
So That Was Life. A Biography of Sir
GeoVrey JeVerson. Author; PETER H
SCHURR. (Pp 358; £25.00). Published by The
Royal Society of Medicine Press Ltd,
London, 1997. ISBN 1-85315-305-2.
Atlas of the Human Brain. Edited by
JURGEN K MAI, JOSEPH ASSHEUER, and GEORGE
PAXINOS. (Pp 328; HB $135.00). Published
by Academic Press, San Diego, 1997. ISBN
0-12-465361-8.
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ganglionopathy: a postmortem case
Subacute autonomic and sensory
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